Rheumaderm pp 135-140 | Cite as

Behçet’s Syndrome

The Cerrahpasa Experience
  • Hasan Yazici
  • I. Fresko
  • V. Hamuryudan
  • C. Mat
  • M. Melikoglu
  • Y. Ozyazgan
  • Y. Tuzun
  • S. Yurdakul
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 455)


Behçet’s syndrome (BS) is a systemic vasculitis of unknown etiology. There are several reasons for doubting a primary autoimmune pathogenesis of this condition. Recent information suggests evidence for genetic anticipation. Although there is heightened inflammatory activity, as exemplified by the pathergy reaction, wound healing in BS is normal. BS also runs a more stormy course in adults and in the young. However, the amount of androgen receptors in scrotal skin have not found to be increased. Another unsolved problem is the nature of acnelike lesions and how they differ from acne vulgaris (AV). Only lesions in “non-acne” areas were compared between the two conditions, and no differences were detected. Mortality is increased in BS, especially among males. Azathioprine proved to be effective in disease control after 8 years of follow-up. We have also recently finished a 24 week controlled trial of two doses of thalidomide, 100 mg and 300 mg per day. Both doses were superior to placebo, with no real differences in efficacy, in controlling the oral and genital ulcers.


Androgen Receptor Familial Mediterranean Fever Genital Ulcer Scrotal Skin Genetic Anticipation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Yurdakul S, Gunaydin I, Tuzun Y, Ozyazgan O, Pazarli H, Yazici H. The prevalence of Behçet’s syndrome in a rural area in Turkey. J. Rheumatol 15: 882–890. (1988)Google Scholar
  2. 2.
    Bird Stewart JA Genetic analysis of families of patients with Behçet’s syndrome: data incompatible with autosomal recessive mode of inheritance. Ann Rheum Dis. 45: 265–268. (1986).CrossRefGoogle Scholar
  3. 3.
    Yazici H. Cicek B. Basaran G, Hamuryudan V, Cakir N, Dimitriatis I, Yurdakul S, Moral F, Ozyazgan Y, Mat C, Tuzun Y. Behçet’s syndrome with emphasis on clinical genetics and mortality. In The Vasculitides — Science and Practice (ed. Ansell, Bacon, Lee and Yazici), Chapman and Hall, London. 199–206. (1996).Google Scholar
  4. 4.
    Tuzun Y, Yazici H, Pazarli H, Yalcin B, Yurdakul S, Muftuoglu A. The usefulness of the nonspecific hypersensitivity (pathergy) test in Behçet’s disease in Turkey. Acta Dermatovener (Stockholm). 59: 77–79. (1979).Google Scholar
  5. 5.
    Cakir N, Yazici H, Chamberlain MA, Barnes CG, Akcasu A, Atasoy S. The response to monosdium urate (MSU) crystals in Behçet’s Syndrome. Ann Rheum Dis. 50: 634–636. (1991)PubMedCrossRefGoogle Scholar
  6. 6.
    Yazici H, Chamberlain MA, Schreuder I, Bird Stewart J, Denman M. HLA B5 and Behçet’s disease. Ann Rheum Dis. 42: 602–603. (1983).PubMedCrossRefGoogle Scholar
  7. 7.
    Fresko I, Soy M, Hamuryudan V, Yurdakul S, Yavuz S, Turner Z, Yazici H. Genetic Anticipation in Behçet’s syndrome. Ann Rheum Dis (in print).Google Scholar
  8. 8.
    Yazici H. The place of Behçet’s syndrome among the autoimmune diseases. Int Rev Immunol. 14(1): 1–10.Google Scholar
  9. 9.
    Eksioglu-Demiralp, personal communication.Google Scholar
  10. 10.
    Stanford MR, Kasp E, Whiston R, Hasan A, Todryk S, Shinnik T, Mizushima Y, Dumonde DC, van der Zee R, Lehner T. Heat shock protein peptides reactive in patients with Behçet’s disease are uveotigenic in Lewis rats. Clin Exp Immunol. 97: 226–231. (1994).PubMedCrossRefGoogle Scholar
  11. 11.
    Hasan A, Fortune F, Wilson A, Warr K, Shinnik T, Mizushima Y, van de Zee Y, Stanford RS, Sanderson J, Lehner T. Role of γδ T cells in pathogenesis and diagnosis of Behçet’s disease. Lancet. 347: 789–794. (1996).PubMedCrossRefGoogle Scholar
  12. 12.
    Lesprit P, Wechsler B, Piette JC, Du-Buotin LT, Godeau P, Alhenc-gelas Aiach M. Activated protein C resistance caused by factor V Arg 506→Gln mutation has no role in thrombotic manifestations of Behçet’s disease. Ann Rheum Dis. 54: 860. (1995).PubMedCrossRefGoogle Scholar
  13. 13.
    Gul A, Ozbek U, Ozturk C, Inane M, Konice M, Ozcelik T. Coagulation factor V gene mutation increases the risk of venous thrombosis in Behçet’s disease. Br J Rheumatol. 35: 1178–1180 (1996).PubMedCrossRefGoogle Scholar
  14. 14.
    Gul A, Esin S, Dilsen N, Konice M, Wigzell H, Biberfield P. The immunology of the skin pathergy reaction in Behçet’s disease. Br J Dermatol. 35: 1178–1180 (1995).Google Scholar
  15. 15.
    Fresko I, Yazici H, Bayramicli M, Yurdakul S, Mat C. Effect of surgical cleaning of the skin on the pathergy phenomenon in Behçet’s syndrome. Ann Rheum Dis. 52: 619–620 (1993).PubMedCrossRefGoogle Scholar
  16. 16.
    Takeno M, Kariyone A, Yamashita N, Takiguchi M, Mizushima Y, Kaneoka H, Sakane T. Excessive function of peripheral blood neutrophils from patients with Behçet’s disease and from HLZA-B51 transgenic mice. Arthritis Rheum. 38: 426–433 (1995).PubMedCrossRefGoogle Scholar
  17. 17.
    Tuzun H, Besirli K, Sayin A, Vural FS, Hamuryudan V, Hizli N, Yurdakul S, Yazici H. Management of aneurysms in Behçet’s syndrome: an analysis of 24 patients. Surgery 12: 150–156. (1997).CrossRefGoogle Scholar
  18. 18.
    Lee J, Lee CW, Song CH, Lee CH, Suh CH, Park YB, Lee WK, Lee SK. Postoperative recurrence in intestinal Behçet’s disease. Arthritis Rheum. 40 (suppl. 1): S66 (1997).Google Scholar
  19. 19.
    Mat C, Nazarbakhi M, Tuzun Y, Hamuryudan V, Hizli N, Yurdakul S, Ozyazgan Y, Yazici H. Wound healing in Behçet’s syndrome. Int J Dermatol (in print).Google Scholar
  20. 20.
    Yazici H, Tuzum Y, Tammam AB, Yurdakul S, Serdaroglu S, Pazarli H, Muftuoglu A. The male patients with Behçet’s syndrome have stronger pathergy reactions. Clin Exp Rheumatol. 3: 137–141. (1985).PubMedGoogle Scholar
  21. 21.
    Yazici H, Basaran G, Hamuryudan V, Hizli N, Yurdakul S, Mat C, Tuzun Y, Oyazgan Y, Dimitriyatis I. The ten-year mortality in Behçet’s syndrome. Br J Rheumatol. 35: 139–141 (1996).PubMedCrossRefGoogle Scholar
  22. 22.
    Mat C, Demirkesen C, Cokerler (Arikan) O, Cetiner B, Fresko I, Yurdakul S, Tuzun Y, Yazici H. Androgen receptor density in scrotat skin of Behçet’s syndrome. In the Book of Abstracts of the Fourth Turkey-Korea Joint Meeting of Behçet s Disease. Kyongju, Korea. 1997.Google Scholar
  23. 23.
    Yazici H, Mat C, Deniz S, Iscimen A, Yurdakul S, Tuzun Y, Hekim N, Yazici Y. Sebum production is increased in Behçet’s syndrome and even more so in rheumatoid arthritis. Clin Exp Rheumatol 5: 371–374. (1987).PubMedGoogle Scholar
  24. 24.
    Jorizzo JL, Abernethy JL, White WL, Mangelsdorf HC, Zouboulis CC, Sarica R, Gaffney K, Mat C, Yazici H, al Dalaan A, Assaad-Khalil SH, Kaneko F. Mucocutaneous criteria for the diagnosis of Behçet’s disease: an analysis of clinicopathological data from multiple international centers. J Am Acad Dermatol. 32: 968–976(1995).PubMedCrossRefGoogle Scholar
  25. 25.
    Ergun T, Gurbuz O, Dogusoy G, Mat C, Yazici H. Histopathological features of the pustular lesions of Behçet’s syndrome. Int J Dermatol (in print).Google Scholar
  26. 26.
    Yazici H, Pazarli H, Barnes CG, Tuzun Y, Ozyazgan Y, Silman A, Serdaroglu S, Oguz V, Yurdakul S, Lovatt G, Yazici B, Somai S, Muftuoglu A. A controlled trial of azathioprine in Behçet’s syndrome. N Eng J Med. 322: 281–285 (1990).CrossRefGoogle Scholar
  27. 27.
    Hamuryudan V, Ozyazgan H, Hizli N, Mat C, Yurdakul S,. Tuzun Y, Senocak M, Yazici H. Azathioprine in Behçet’s syndrome. Arthritis Rheum 40: 769–774 (1997).PubMedCrossRefGoogle Scholar
  28. 28.
    Hamuryudan V, Mat C, Saip S, Ozyagzan Y, Siva A, Yurdakul S, Zwingenberger K, Yazici H. Randomised and placebo controlled trial of two different doses of thalidomide in Behçet’s syndrome. Arthritis Rheum. 40(suppl 1): S65(1997).CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1999

Authors and Affiliations

  • Hasan Yazici
    • 1
  • I. Fresko
    • 1
  • V. Hamuryudan
    • 1
  • C. Mat
    • 1
  • M. Melikoglu
    • 1
  • Y. Ozyazgan
    • 1
  • Y. Tuzun
    • 1
  • S. Yurdakul
    • 1
  1. 1.University of IstanbulIstanbulTurkey

Personalised recommendations